Doenças pulmonares císticas difusas: diagnóstico diferencial
Carregando...
Citações na Scopus
28
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
Autores
MARCHIORI, Edson
HOCHHEGGER, Bruno
Citação
JORNAL BRASILEIRO DE PNEUMOLOGIA, v.43, n.2, p.140-149, 2017
Resumo
As doenças pulmonares císticas difusas se caracterizam pela presença de cistos envolvendo mais de um lobo pulmonar, que se originam por diversos mecanismos, incluindo dilatação dos espaços aéreos distais por obstrução, necrose das paredes das vias aéreas e destruição do parênquima. Essas doenças apresentam evolução variável. A TCAR é fundamental na avaliação dessas doenças uma vez que permite uma melhor caracterização dos cistos pulmonares, incluindo sua distribuição, tamanho, extensão e regularidade das paredes, assim como a determinação de outras lesões pulmonares e extrapulmonares associadas. Frequentemente a TCAR é suficiente para a definição etiológica dos cistos pulmonares difusos, associada a achados clínicos e laboratoriais, sem a necessidade de realização de biópsia pulmonar. O diagnóstico diferencial das doenças pulmonares císticas difusas é extenso, incluindo etiologias neoplásicas, inflamatórias e infecciosas, sendo as mais frequentes determinantes desse padrão tomográfico a histiocitose pulmonar de células de Langerhans, a linfangioleiomiomatose, a pneumonia intersticial linfocitária e a bronquiolite folicular. Novas etiologias foram incluídas como potenciais determinantes desse padrão.
Diffuse cystic lung diseases are characterized by cysts in more than one lung lobe, the cysts originating from various mechanisms, including the expansion of the distal airspaces due to airway obstruction, necrosis of the airway walls, and parenchymal destruction. The progression of these diseases is variable. One essential tool in the evaluation of these diseases is HRCT, because it improves the characterization of pulmonary cysts (including their distribution, size, and length) and the evaluation of the regularity of the cyst wall, as well as the identification of associated pulmonary and extrapulmonary lesions. When combined with clinical and laboratory findings, HRCT is often sufficient for the etiological definition of diffuse lung cysts, avoiding the need for lung biopsy. The differential diagnoses of diffuse cystic lung diseases are myriad, including neoplastic, inflammatory, and infectious etiologies. Pulmonary Langerhans cell histiocytosis, lymphangioleiomyomatosis, lymphocytic interstitial pneumonia, and follicular bronchiolitis are the most common diseases that produce this CT pattern. However, new diseases have been included as potential determinants of this pattern.
Diffuse cystic lung diseases are characterized by cysts in more than one lung lobe, the cysts originating from various mechanisms, including the expansion of the distal airspaces due to airway obstruction, necrosis of the airway walls, and parenchymal destruction. The progression of these diseases is variable. One essential tool in the evaluation of these diseases is HRCT, because it improves the characterization of pulmonary cysts (including their distribution, size, and length) and the evaluation of the regularity of the cyst wall, as well as the identification of associated pulmonary and extrapulmonary lesions. When combined with clinical and laboratory findings, HRCT is often sufficient for the etiological definition of diffuse lung cysts, avoiding the need for lung biopsy. The differential diagnoses of diffuse cystic lung diseases are myriad, including neoplastic, inflammatory, and infectious etiologies. Pulmonary Langerhans cell histiocytosis, lymphangioleiomyomatosis, lymphocytic interstitial pneumonia, and follicular bronchiolitis are the most common diseases that produce this CT pattern. However, new diseases have been included as potential determinants of this pattern.
Palavras-chave
Cistos, Diagnóstico diferencial, Doenças pulmonares intersticiais, Tomografia computadorizada por raios X, Cysts, Diagnosis, differential, Lung diseases, interstitial, tomography, X-ray computed
Referências
- Akira M, 1997, THORAX, V52, P333
- Barker AF, 2014, NEW ENGL J MED, V370, P1820, DOI 10.1056/NEJMra1204664
- Barreto MM, 2012, RADIOGRAPHICS, V32, P71, DOI 10.1148/rg.321115052
- CHAUDHUR.MR, 1970, THORAX, V25, P375, DOI 10.1136/thx.25.3.375
- Colombat M, 2006, AM J RESP CRIT CARE, V173, P777, DOI 10.1164/rccm.200510-1620CR
- Costa AN, 2013, J BRAS PNEUMOL, V39, P368, DOI 10.1590/S1806-37132013000300015
- DeMartino E, 2016, CLIN CHEST MED, V37, P421, DOI 10.1016/j.ccm.2016.04.005
- Desai SR, 1997, J THORAC IMAG, V12, P215, DOI 10.1097/00005382-199707000-00009
- DODD GD, 1961, AMER J ROENTGENOL RA, V85, P277
- Francisco FA Ferreira, 2015, EUR RESPIR REV, V24, P552
- Franquet T, 2003, J COMPUT ASSIST TOMO, V27, P475, DOI 10.1097/00004728-200307000-00003
- Gilroy SA, 2011, SEMIN RESP CRIT CARE, V32, P775, DOI 10.1055/s-0031-1295725
- Baldi BG, 2014, SARCOIDOSIS VASC DIF, V31, P129
- Guinee DG, 2010, ARCH PATHOL LAB MED, V134, P691, DOI 10.1043/1543-2165-134.5.691
- Gupta N, 2015, AM J RESP CRIT CARE, V192, P17, DOI 10.1164/rccm.201411-2096CI
- Gupta N, 2015, AM J RESP CRIT CARE, V191, P1354, DOI 10.1164/rccm.201411-2094CI
- Hardak E, 2010, LUNG, V188, P159, DOI 10.1007/s00408-009-9214-y
- Jeong YJ, 2004, J COMPUT ASSIST TOMO, V28, P776, DOI 10.1097/00004728-200411000-00008
- Kawano-Dourado L, 2012, AM J RESP CRIT CARE, V186, P294
- McCormack FX, 2016, AM J RESP CRIT CARE, V194, P748, DOI 10.1164/rccm.201607-1384ST
- Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3
- Morell F, 2016, SEMIN RESP CRIT CARE, V37, P395, DOI 10.1055/s-0036-1580692
- Panchabhai TS, 2016, CLIN CHEST MED, V37, P463, DOI 10.1016/j.ccm.2016.04.009
- Queiroz-Telles F, 2011, SEMIN RESP CRIT CARE, V32, P764, DOI 10.1055/s-0031-1295724
- QUIGLEY MJ, 1988, AM J ROENTGENOL, V150, P1275
- Seo JB, 2001, RADIOGRAPHICS, V21, P403
- Silva CIS, 2010, J BRAS PNEUMOL, V36, P99, DOI 10.1590/S1806-37132010000100016
- Tobino K, 2011, EUR J RADIOL, V77, P403, DOI 10.1016/j.ejrad.2009.09.004
- Toro JR, 2007, AM J RESP CRIT CARE, V175, P1044, DOI 10.1164/rccm.200610-1483OC
- Xu KF, 2016, SEMIN RESP CRIT CARE, V37, P457, DOI 10.1055/s-0036-1580690